Reduced intensity reinduction followed by blinatumomab achieves excellent MRD clearance with reduced toxicity and facilitates timely transplant in children and young people with relapsed B-precursor acute lymphoblastic leukemia

التفاصيل البيبلوغرافية
العنوان: Reduced intensity reinduction followed by blinatumomab achieves excellent MRD clearance with reduced toxicity and facilitates timely transplant in children and young people with relapsed B-precursor acute lymphoblastic leukemia
المؤلفون: Hodder, A., Mishra, A. K., Clesham, K., Baird, S., Bhuller, K., Bisho, I., Bonney, D., Castleton, Anna, Cummins, M., Dickens, E., George, L., Ghorashian, S., Gibson, B., Hasley, C., Heaney, N., Hough, R. E., Ingham, D., Jigoulina, G., Lindsay, K., Lancaster, D., Madni, M., Malone, A., Mitchell, B., Moorman, A. V., Moppett, J., McLelland, V., Motwani, J., Nicholson, E., Osborne, C., Patrick, K., Samrin, L., Tewari, S., Thakur, I. R., Samarasinghe, S., Vora, A., O'Connor, D.
المساهمون: Department of Haematology, Great Ormond Street Hospital for Children, London
سنة النشر: 2022
المجموعة: The Christie School of Oncology: Christie Research Publications Repository
نوع الوثيقة: conference object
اللغة: English
العلاقة: https://dx.doi.org/10.1182/blood-2022-162565Test; Hodder A, Mishra AK, Clesham K, Baird S, Bhuller K, Bisho I, et al. Reduced Intensity Reinduction Followed By Blinatumomab Achieves Excellent MRD Clearance with Reduced Toxicity and Facilitates Timely Transplant in Children and Young People with Relapsed B-Precursor Acute Lymphoblastic Leukemia. Blood. 2022 Nov;140:3268-70. PubMed PMID: WOS:000893223203136.; http://hdl.handle.net/10541/626121Test; Blood
DOI: 10.1182/blood-2022-162565
الإتاحة: https://doi.org/10.1182/blood-2022-162565Test
http://hdl.handle.net/10541/626121Test
رقم الانضمام: edsbas.842D336A
قاعدة البيانات: BASE